What does it take to go from helping millions of people breathe easier to helping patients keep their legs?Join The Heart of Innovation as Kym McNicholas talks with Sarvajna Dwivedi, Ph.D., entrepreneur, inventor, and CEO of AngioSafe, whose career has spanned some of the most challenging problems in medicine.Sarvajna co-founded Pearl Therapeutics, a company focused on breakthrough respiratory therapies that was ultimately acquired by AstraZeneca for $1.15 billion. Along the way, he helped develop inhaled therapies and drug-device combinations designed to improve the lives of patients with asthma and COPD. (AngioSafe United States)Today, his focus has shifted from the lungs to the arteries.As CEO and co-founder of AngioSafe, Sarvajna is leading the development of the Santreva-ATK Endovascular Revascularization Catheter, a novel device designed to restore blood flow through some of the most challenging chronic total occlusions (CTOs) physicians encounter in patients with peripheral artery disease (PAD). The technology is designed to cross completely blocked arteries, compress plaque, create a new channel, and restore blood flow without relying on a guidewire or external power source. (Medical Economics)In this episode, we discuss:• How a pharmaceutical scientist became a medical device innovator  • The story behind Pearl Therapeutics and its $1.15 billion acquisition  • Why chronic total occlusions remain one of the biggest challenges in PAD treatment  • How AngioSafe's Santreva-ATK technology works  • What it means to restore blood flow through arteries that are 100% blocked  • The future of cardiovascular and vascular innovationIf you or someone you love has peripheral artery disease, diabetes, leg pain while walking, non-healing wounds, or has been told an artery is completely blocked, this is a conversation you won't want to miss.📞 Need help navigating PAD care? Call the Leg Saver Hotline: 1-833-PAD-LEGS🌐 Learn more:PADHelp.org▶ Subscribe:@TheWayToMyHeart👍 Like, subscribe, and share to help us spread awareness of PAD, a disease that is more prevalent and deadlier than many cancers combined, yet remains dramatically underdiagnosed.#PAD #PeripheralArteryDisease #SarvajnaDwivedi #AngioSafe #SantrevaATK #HeartOfInnovation #VascularDisease #CardiovascularInnovation #MedTech #LimbSalvage #CTO #Endovascular #AstraZeneca #Asthma #MedicalInnovation

<div data-olk-copy-source="MessageBody">What does it take to go from helping millions of people breathe easier to helping patients keep their legs?</div> <div> </div> <div>Join The Heart of Innovation as Kym McNicholas talks with Sarvajna Dwivedi, Ph.D., entrepreneur, inventor, and CEO of AngioSafe, whose career has spanned some of the most challenging problems in medicine.</div> <div> </div> <div>Sarvajna co-founded Pearl Therapeutics, a company focused on breakthrough respiratory therapies that was ultimately acquired by AstraZeneca for $1.15 billion. Along the way, he helped develop inhaled therapies and drug-device combinations designed to improve the lives of patients with asthma and COPD. (AngioSafe United States)</div> <div> </div> <div>Today, his focus has shifted from the lungs to the arteries.</div> <div> </div> <div>As CEO and co-founder of AngioSafe, Sarvajna is leading the development of the Santreva-ATK Endovascular Revascularization Catheter, a novel device designed to restore blood flow through some of the most challenging chronic total occlusions (CTOs) physicians encounter in patients with peripheral artery disease (PAD). The technology is designed to cross completely blocked arteries, compress plaque, create a new channel, and restore blood flow without relying on a guidewire or external power source. (Medical Economics)</div> <div> </div> <div>In this episode, we discuss:</div> <div> </div> <div>• How a pharmaceutical scientist became a medical device innovator  </div> <div>• The story behind Pearl Therapeutics and its $1.15 billion acquisition  </div> <div>• Why chronic total occlusions remain one of the biggest challenges in PAD treatment  </div> <div>• How AngioSafe's Santreva-ATK technology works  </div> <div>• What it means to restore blood flow through arteries that are 100% blocked  </div> <div>• The future of cardiovascular and vascular innovation</div> <div> </div> <div>If you or someone you love has peripheral artery disease, diabetes, leg pain while walking, non-healing wounds, or has been told an artery is completely blocked, this is a conversation you won't want to miss.</div> <div> </div> <div>📞 Need help navigating PAD care? Call the Leg Saver Hotline: 1-833-PAD-LEGS</div> <div> </div> <div>🌐 Learn more:</div> <div>PADHelp.org</div> <div> </div> <div>▶ Subscribe:</div> <div>@TheWayToMyHeart</div> <div> </div> <div>👍 Like, subscribe, and share to help us spread awareness of PAD, a disease that is more prevalent and deadlier than many cancers combined, yet remains dramatically underdiagnosed.</div> <div> </div> <div>#PAD #PeripheralArteryDisease #SarvajnaDwivedi #AngioSafe #SantrevaATK #HeartOfInnovation #VascularDisease #CardiovascularInnovation #MedTech #LimbSalvage #CTO #Endovascular #AstraZeneca #Asthma #MedicalInnovation</div>

All of us have the power to create change. The advances in technology are now such that if you have an idea, it’s easier than ever to execute on it. “Kym McNicholas On Innovation” shares the journeys of successful entrepreneurs, innovators, and investors from around the world who will inspire you to create your own financial independence. The show also features some of the most advanced technologies you’ve never heard of that could be have an impact on your life, your business, and your career. 

Regular featured segments include “The Edge” which highlights businesses that are game-changing in the enterprise. Plus, each week in “HealthTech”, you’ll hear about a company that’s creating better, safer, faster, and cheaper technologies that will improve patient care and lower costs. And in our “Female Seeking Startup” series hear the success stories of some of the most powerful women who are creating game-changing technologies.

Produced and Published by The Innovators Network (http://TheInnovators.Network)

The Heart of Innovation with Kym McNicholas

The Heart of Innovation is 60 minutes with life and limb saving potential. Emmy Award-winning Journalist and Patient Navigator Kym McNicholas and Interventional Cardiologist Dr. John Phillips discuss new exciting ideas and innovation in healthcare. They tackle some of the greatest barriers to timely, effective patient care and discuss solutions with physicians, clinicians, policy makers, and most importantly, patients.

<p>The Heart of Innovation is 60 minutes with life and limb saving potential. Emmy Award-winning Journalist and Patient Navigator Kym McNicholas and Interventional Cardiologist Dr. John Phillips discuss new exciting ideas and innovation in healthcare. They tackle some of the greatest barriers to timely, effective patient care and discuss solutions with physicians, clinicians, policy makers, and most importantly, patients.</p>